Meihua International Medical Technologies Co., Ltd.(MHUA)Earnings, Financials & Key Ratios
MHUA•NASDAQ
0.2× P/E·Price updated Apr 24, 2026
AboutMeihua International Medical Technologies Co., Ltd. engages in the manufacture and marketing of medical consumables in the People's Republic of China. It offers class I, II, and III disposable medical devices. The company's products include non-bottled products, such as brushes and ID bracelets; and polyethylene bottled products, such as eye drop and tablet bottles. It also distributes disposable medical devices sourced from other manufacturers to customers in China. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China. Meihua International Medical Technologies Co., Ltd. operates as a subsidiary of Bright Accomplish Limited.Show more
- Revenue$97M-0.2%
- EBITDA$15M-1.7%
- Net Income$11M-6.7%
- EPS (Diluted)40.00-18.4%
- Gross Margin34.36%+0.8%
- EBITDA Margin15.36%-1.5%
- Operating Margin14.77%-2.3%
- Net Margin11.19%-6.5%
- ROE7.09%-12.9%
MHUA Key Insights
Meihua International Medical Technologies Co., Ltd. (MHUA) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓High quality earnings: Operating CF exceeds net income
- ✓Healthy 5Y average net margin of 14.1%
- ✓Trading at only 0.0x book value
✗Weaknesses
- ✗Weak momentum: RS Rating 5 (bottom 5%)
- ✗Shares diluted 14.3% in last year
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when MHUA posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
MHUA Price & Volume
Meihua International Medical Technologies Co., Ltd. (MHUA) stock price & volume — 10-year historical chart
Loading chart...
MHUA Growth Metrics
Meihua International Medical Technologies Co., Ltd. (MHUA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years4.01%
3 Years-2.34%
TTM-11.3%
Profit CAGR
10 Years-
5 Years-6.81%
3 Years-19.71%
TTM-26.27%
EPS CAGR
10 Years-
5 Years-8.97%
3 Years-23.4%
TTM-44.54%
Return on Capital
10 Years24.07%
5 Years17.63%
3 Years9.45%
Last Year9.36%
MHUA Peer Comparison
Meihua International Medical Technologies Co., Ltd. (MHUA) competitors in Drug delivery and infusion consumables — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 CODA | 112.81M | 10.00 | 27.03 | 30.75% | 17.66% | 8.33% | 0.01 | |
 ATEC | 1.33B | 8.81 | -9.18 | 24.95% | -21.07% | -443.09% | 17.21 | |
 XTLB | 279.46K | 2.54 | -0.26 | -227.72% | -25.53% | 0.03 | ||
 MMSI | 4.01B | 67.22 | 31.56 | 11.66% | 9.03% | 8.95% | 0.57 | |
 NVCR | 1.62B | 14.28 | -11.70 | 8.28% | -25.66% | -50.82% | 0.85 | |
 INVA | 1.66B | 22.49 | 6.82 | 18.52% | 118.91% | 47.59% | 0.23 | |
 ANGO | 505.13M | 12.15 | -14.64 | -3.76% | -9.02% | -15.71% | ||
 MDT | 101.86B | 79.34 | 21.98 | 3.62% | 13% | 9.49% | 0.59 |
Compare MHUA vs Peers
Meihua International Medical Technologies Co., Ltd. (MHUA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
MHUA Income Statement
Meihua International Medical Technologies Co., Ltd. (MHUA) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 75.71M | 79.63M | 89.06M | 104.04M | 103.35M | 97.1M | 96.91M | 183.8M |
Revenue Growth % | - | 5.18% | 11.85% | 16.82% | -0.66% | -6.05% | -0.19% | -11.3% |
Cost of Goods Sold | 43.82M | 47.42M | 51.9M | 64.23M | 65.25M | 64M | 63.61M | 122.05M |
COGS % of Revenue | 57.88% | 59.55% | 58.28% | 61.74% | 63.14% | 65.92% | 65.64% | - |
Gross Profit | 31.89M▲ 0% | 32.21M▲ 1.0% | 37.16M▲ 15.4% | 39.81M▲ 7.1% | 38.1M▼ 4.3% | 33.09M▼ 13.1% | 33.3M▲ 0.6% | 61.75M▲ 0% |
Gross Margin % | 42.12% | 40.45% | 41.72% | 38.26% | 36.86% | 34.08% | 34.36% | 33.6% |
Gross Profit Growth % | - | 1.01% | 15.37% | 7.12% | -4.29% | -13.13% | 0.62% | - |
Operating Expenses | 13.1M | 12.82M | 13.69M | 14.5M | 22.54M | 18.42M | 18.99M | 38.64M |
OpEx % of Revenue | 17.3% | 16.1% | 15.38% | 13.94% | 21.81% | 18.97% | 19.59% | - |
Selling, General & Admin | 9.85M | 8.68M | 10.34M | 11.78M | 18.68M | 12.97M | 13.52M | 32.22M |
SG&A % of Revenue | 13.01% | 10.9% | 11.61% | 11.32% | 18.07% | 13.35% | 13.95% | - |
Research & Development | 2.87M | 3.21M | 2.49M | 2.73M | 2.96M | 2.75M | 3.46M | 6.08M |
R&D % of Revenue | 3.78% | 4.04% | 2.8% | 2.62% | 2.87% | 2.84% | 3.57% | - |
Other Operating Expenses | 0 | 926.2K | 864.79K | 0 | 898.66K | 2.7M | 2.01M | 340.9K |
Operating Income | 19.18M▲ 0% | 19.39M▲ 1.1% | 23.47M▲ 21.0% | 26.26M▲ 11.9% | 10.8M▼ 58.9% | 14.67M▲ 35.9% | 14.31M▼ 2.5% | 23.13M▲ 0% |
Operating Margin % | 25.33% | 24.35% | 26.35% | 25.24% | 10.45% | 15.11% | 14.77% | 12.58% |
Operating Income Growth % | - | 1.1% | 21.04% | 11.91% | -58.87% | 35.85% | -2.47% | - |
EBITDA | 19.74M | 19.9M | 23.99M | 26.88M | 11.37M | 15.15M | 14.88M | 24.15M |
EBITDA Margin % | 26.08% | 24.99% | 26.94% | 25.84% | 11% | 15.6% | 15.36% | 13.14% |
EBITDA Growth % | - | 0.77% | 20.57% | 12.06% | -57.72% | 33.26% | -1.74% | -32.11% |
D&A (Non-Cash Add-back) | 567.77K | 509.22K | 523.43K | 622.47K | 563.46K | 470.99K | 571.03K | 1.02M |
EBIT | 19.18M | 19.35M | 23.87M | 26.41M | 11.09M | 15.3M | 15.13M | 23.83M |
Net Interest Income | 0 | -48.95K | -100.58K | -156.89K | -130.94K | 622.66K | -492.3K | 2.73M |
Interest Income | 77.42K | 48.84K | 36.58K | 23.86K | 63.73K | 873.44K | 1.01M | 3.48M |
Interest Expense | 0 | 97.79K | 137.16K | 180.74K | 194.67K | 250.78K | 1.51M | 747.74K |
Other Income/Expense | -465.98K | -137.69K | 267.35K | -32.91K | 89.28K | 373.84K | -685.78K | 252.69K |
Pretax Income | 18.71M▲ 0% | 19.25M▲ 2.9% | 23.73M▲ 23.3% | 26.23M▲ 10.5% | 10.89M▼ 58.5% | 15.05M▲ 38.2% | 13.63M▼ 9.5% | 23.38M▲ 0% |
Pretax Margin % | 24.72% | 24.18% | 26.65% | 25.21% | 10.54% | 15.5% | 14.06% | 12.72% |
Income Tax | 3.23M | 3.82M | 4.69M | 5.28M | 4.71M | 3.46M | 2.79M | 4.84M |
Effective Tax Rate % | 17.28% | 19.84% | 19.75% | 20.13% | 43.28% | 22.98% | 20.47% | 20.7% |
Net Income | 15.48M▲ 0% | 15.43M▼ 0.3% | 19.05M▲ 23.4% | 20.95M▲ 10.0% | 6.24M▼ 70.2% | 11.63M▲ 86.2% | 10.84M▼ 6.7% | 18.55M▲ 0% |
Net Margin % | 20.44% | 19.38% | 21.38% | 20.14% | 6.04% | 11.97% | 11.19% | 10.09% |
Net Income Growth % | - | -0.3% | 23.42% | 10% | -70.2% | 86.22% | -6.73% | -26.27% |
Net Income (Continuing) | 15.48M | 15.43M | 19.05M | 20.95M | 6.18M | 11.59M | 10.84M | 18.54M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 556.14K | 505.98K | 0 | 0 |
EPS (Diluted) | 77.00▲ 0% | 64.00▼ 16.9% | 79.00▲ 23.4% | 89.00▲ 12.7% | 27.00▼ 69.7% | 49.00▲ 81.5% | 40.00▼ 18.4% | 58.15▲ 0% |
EPS Growth % | - | -16.88% | 23.44% | 12.66% | -69.66% | 81.48% | -18.37% | -44.54% |
EPS (Basic) | 77.00 | 64.00 | 79.00 | 89.00 | 27.00 | 49.00 | 40.00 | - |
Diluted Shares Outstanding | 200K | 241.4K | 241.4K | 236K | 234.11K | 239.4K | 273.72K | 319.05K |
Basic Shares Outstanding | 200K | 241.4K | 241.4K | 236K | 234.11K | 239.4K | 273.72K | 319.05K |
Dividend Payout Ratio | - | - | - | - | - | - | - | - |
MHUA Balance Sheet
Meihua International Medical Technologies Co., Ltd. (MHUA) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|
Total Current Assets | 49.97M | 52.58M | 67.57M | 97.28M | 135.32M | 132.24M | 143.44M | 146.34M |
Cash & Short-Term Investments | 14.8M | 16.03M | 7.19M | 8.15M | 26.74M | 16.93M | 15.96M | 15.55M |
Cash Only | 14.8M | 16.03M | 7.19M | 8.15M | 26.74M | 16.93M | 15.96M | 15.55M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 32.98M | 35.41M | 58.56M | 86.48M | 91.03M | 99.48M | 115M | 117.67M |
Days Sales Outstanding | 159 | 162.33 | 239.98 | 303.41 | 321.51 | 373.95 | 433.13 | 218.14 |
Inventory | 1.84M | 1.02M | 1.33M | 1.25M | 1.12M | 1.62M | 1.41M | 1.1M |
Days Inventory Outstanding | 15.36 | 7.89 | 9.33 | 7.11 | 6.28 | 9.22 | 8.09 | 3.9 |
Other Current Assets | 344.84K | 107.94K | 496.61K | 1.39M | 16.43M | 14.23M | 1.48M | 12.03M |
Total Non-Current Assets | 12.45M | 20.63M | 38.48M | 39.58M | 28.26M | 39.68M | 42.8M | 44.24M |
Property, Plant & Equipment | 3.7M | 3.4M | 20.13M | 7.48M | 8.76M | 8.84M | 7.89M | 7.78M |
Fixed Asset Turnover | 20.46x | 23.41x | 4.42x | 13.91x | 11.80x | 10.99x | 12.29x | 22.49x |
Goodwill | 0 | 0 | 0 | -17.26M | 0 | 0 | 0 | 0 |
Intangible Assets | 600.78K | 16.37M | 17.43M | 17.82M | 497.6K | 3.92M | 443.04K | 443.65K |
Long-Term Investments | 872.66K | 861.85K | 919.54K | 941.53K | 6.67M | 6.13M | 22.39M | 60.04M |
Other Non-Current Assets | 7.27M | 15.8M | 29.89M | 30.6M | 12.33M | 20.42M | 11.09M | 13.15M |
Total Assets | 62.42M▲ 0% | 73.2M▲ 17.3% | 106.05M▲ 44.9% | 136.86M▲ 29.1% | 163.58M▲ 19.5% | 171.92M▲ 5.1% | 186.24M▲ 8.3% | 190.58M▲ 0% |
Asset Turnover | 1.21x | 1.09x | 0.84x | 0.76x | 0.63x | 0.56x | 0.52x | 1.01x |
Asset Growth % | - | 17.28% | 44.87% | 29.05% | 19.52% | 5.1% | 8.33% | 29.98% |
Total Current Liabilities | 17.96M | 13.55M | 21.31M | 29.09M | 24.17M | 25.07M | 27.26M | 25.64M |
Accounts Payable | 13.73M | 9.36M | 15.64M | 20.98M | 16.1M | 15.82M | 15.48M | 11.35M |
Days Payables Outstanding | 114.33 | 72.05 | 109.98 | 119.22 | 90.04 | 90.23 | 88.8 | 43.74 |
Short-Term Debt | 2.04M | 2.59M | 3.22M | 5.18M | 6.09M | 7.32M | 7.95M | 11.45M |
Deferred Revenue (Current) | 0 | 0 | 1.75M | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 956.04K | 851.17K | -494.98K | 0 | 0 | 409.89K | 1.33M | 1.35M |
Current Ratio | 2.78x | 3.88x | 3.17x | 3.34x | 5.60x | 5.27x | 5.26x | 5.71x |
Quick Ratio | 2.68x | 3.81x | 3.11x | 3.30x | 5.55x | 5.21x | 5.21x | 5.66x |
Cash Conversion Cycle | 60.03 | 98.17 | 139.33 | 191.29 | 237.74 | 292.95 | 352.42 | 178.3 |
Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 724.93K | 4.59K | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 724.93K | 0 | 0 | 0 |
Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 4.59K | 0 | 4.59K |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 17.96M | 13.55M | 21.31M | 30.05M | 24.9M | 25.08M | 27.26M | 25.64M |
Total Debt | 2.04M | 2.59M | 3.22M | 5.18M | 6.81M | 7.33M | 7.95M | 11.45M |
Net Debt | -12.77M | -13.45M | -3.97M | -2.97M | -19.92M | -9.6M | -8.01M | -4.1M |
Debt / Equity | 0.05x | 0.04x | 0.04x | 0.05x | 0.05x | 0.05x | 0.05x | 0.07x |
Debt / EBITDA | 0.10x | 0.13x | 0.13x | 0.19x | 0.60x | 0.48x | 0.53x | 0.47x |
Net Debt / EBITDA | -0.65x | -0.68x | -0.17x | -0.11x | -1.75x | -0.63x | -0.54x | -0.17x |
Interest Coverage | - | 198.26x | 171.09x | 145.29x | 55.49x | 58.52x | 9.50x | 31.87x |
Total Equity | 44.46M▲ 0% | 59.66M▲ 34.2% | 84.74M▲ 42.0% | 106.81M▲ 26.1% | 138.68M▲ 29.8% | 146.84M▲ 5.9% | 158.98M▲ 8.3% | 164.95M▲ 0% |
Equity Growth % | - | 34.18% | 42.04% | 26.05% | 29.84% | 5.88% | 8.27% | 31.73% |
Book Value per Share | 222.31 | 247.13 | 351.02 | 452.59 | 592.36 | 613.36 | 580.80 | 517.00 |
Total Shareholders' Equity | 44.46M | 59.66M | 84.74M | 106.81M | 138.12M | 146.33M | 158.98M | 164.95M |
Common Stock | 10K | 10K | 10K | 10K | 11.97K | 11.97K | 15.95K | 15.95K |
Retained Earnings | 37.33M | 52.76M | 56.63M | 76.62M | 83.33M | 94.64M | 105.23M | 124.61M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | -200K | -200K |
Accumulated OCI | -2.59M | -2.83M | 18.38M | 20.47M | 11.81M | 8.72M | 4.71M | -8.7M |
Minority Interest | 0 | 0 | 0 | 0 | 556.14K | 505.98K | 0 | 0 |
MHUA Cash Flow Statement
Meihua International Medical Technologies Co., Ltd. (MHUA) cash flow — operating, investing & free cash flow history
| Metric | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|
Cash from Operations | 11.82M | 9.31M | 5.33M | -54.66K | -9.16M | 2.28M | 14.64M | 2.53M |
Operating CF Margin % | 15.61% | 11.69% | 5.98% | -0.05% | -8.87% | 2.34% | 15.1% | - |
Operating CF Growth % | - | -21.23% | -42.78% | -101.03% | -16662.78% | 124.84% | 543.16% | -1189.6% |
Net Income | 15.48M | 15.43M | 19.05M | 19.99M | 6.18M | 11.59M | 10.84M | 18.55M |
Depreciation & Amortization | 567.77K | 509.22K | 523.43K | 622.47K | 563.46K | 470.99K | 571.03K | 1.02M |
Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes | 0 | 0 | 0 | 0 | 0 | -370.48K | -642.63K | 0 |
Other Non-Cash Items | 6.71M | -9.53K | 2.85K | 15.28K | 4.51M | 2.18M | 3.9M | -5.99M |
Working Capital Changes | -10.94M | -6.62M | -14.25M | -20.68M | -20.41M | -11.6M | -27.97K | -11.05M |
Change in Receivables | -11.09M | -4.71M | -13.64M | -20.07M | -7.12M | -14.02M | -3.21M | -13.91M |
Change in Inventory | -170.6K | 802.61K | -219.79K | 105.12K | 35.03K | -528.63K | 165.76K | 575.72K |
Change in Payables | 0 | -4.23M | 5.34M | 4.91M | -3.37M | 185.9K | 932.49K | 0 |
Cash from Investing | -7.57M | -8.9M | -16.09M | -833.82K | -8.62M | -12.46M | -20.42M | -16.84M |
Capital Expenditures | -12.3K | -8.95M | -16.12M | -850.23K | -2.7M | -1.18M | -133.55K | -324.57K |
CapEx % of Revenue | 0.02% | 11.24% | 18.1% | 0.82% | 2.61% | 1.22% | 0.14% | 0.18% |
Acquisitions | 0 | 50.6K | 25.2K | 16.41K | 658.46K | 0 | -89.72K | 0 |
Investments | - | - | - | - | - | - | - | - |
Other Investing | -7.56M | 0 | 0 | 0 | 23.15K | -11.63M | -15.9M | -16.51M |
Cash from Financing | -4.2M | 923.77K | 1.71M | 1.86M | 37.25M | 706.13K | 6.21M | 12.82M |
Debt Issued (Net) | 0 | 579.03K | 434.52K | 1.86M | 2.08M | 706.13K | 6.41M | 6.62M |
Equity Issued (Net) | 0 | 0 | 1000K | 0 | 1000K | 0 | -200K | -200K |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | -200K | -200K |
Other Financing | -4.2M | 344.74K | 0 | 0 | 635.31K | 0 | 0 | 6.4M |
Net Change in Cash | -794.34K▲ 0% | 1.23M▲ 254.5% | -8.84M▼ 820.6% | 961.94K▲ 110.9% | 18.59M▲ 1832.3% | -9.81M▼ 152.8% | 362.07K▲ 103.7% | -71.78K▲ 0% |
Free Cash Flow | 11.8M▲ 0% | 356.12K▼ 97.0% | -10.79M▼ 3130.9% | -904.89K▲ 91.6% | -11.86M▼ 1210.8% | -2.41M▲ 79.7% | 14.5M▲ 701.6% | 12.11M▲ 0% |
FCF Margin % | 15.59% | 0.45% | -12.12% | -0.87% | -11.48% | -2.48% | 14.97% | 6.59% |
FCF Growth % | - | -96.98% | -3130.93% | 91.62% | -1210.85% | 79.68% | 701.59% | 157.8% |
FCF per Share | 59.02 | 1.48 | -44.71 | -3.83 | -50.67 | -10.07 | 52.99 | 37.96 |
FCF Conversion (FCF/Net Income) | 0.76x | 0.60x | 0.28x | -0.00x | -1.47x | 0.20x | 1.35x | 0.65x |
Interest Paid | 0 | 97.79K | 137.16K | 180.74K | 194.67K | 250.78K | 247.62K | 129.86K |
Taxes Paid | 0 | 3.9M | 4.36M | 5.04M | 5.7M | 3.58M | 3.66M | 0 |
MHUA Key Ratios
Meihua International Medical Technologies Co., Ltd. (MHUA) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 29.64% | 26.38% | 21.87% | 5.09% | 8.14% | 7.09% | 11.25% |
Return on Invested Capital (ROIC) | 37.33% | 27.72% | 21.34% | 7.28% | 8.6% | 7.45% | 11.72% |
Gross Margin | 40.45% | 41.72% | 38.26% | 36.86% | 34.08% | 34.36% | 33.6% |
Net Margin | 19.38% | 21.38% | 20.14% | 6.04% | 11.97% | 11.19% | 10.09% |
Debt / Equity | 0.04x | 0.04x | 0.05x | 0.05x | 0.05x | 0.05x | 0.07x |
Interest Coverage | 198.26x | 171.09x | 145.29x | 55.49x | 58.52x | 9.50x | 31.87x |
FCF Conversion | 0.60x | 0.28x | -0.00x | -1.47x | 0.20x | 1.35x | 0.65x |
Revenue Growth | 5.18% | 11.85% | 16.82% | -0.66% | -6.05% | -0.19% | -11.3% |
Related:MHUA Dividend History·MHUA Revenue History·MHUA Price History·MHUA P/E History·MHUA Financial Ratios·MHUA Institutional Holders
MHUA Frequently Asked Questions
Meihua International Medical Technologies Co., Ltd. (MHUA) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Meihua International Medical Technologies Co., Ltd. (MHUA) reported $183.8M in revenue for fiscal year 2024. This represents a 143% increase from $75.7M in 2018.
Meihua International Medical Technologies Co., Ltd. (MHUA) saw revenue decline by 0.2% over the past year.
Yes, Meihua International Medical Technologies Co., Ltd. (MHUA) is profitable, generating $18.6M in net income for fiscal year 2024 (11.2% net margin).
Dividend & Returns
Meihua International Medical Technologies Co., Ltd. (MHUA) has a return on equity (ROE) of 7.1%. This is below average, suggesting room for improvement.
Meihua International Medical Technologies Co., Ltd. (MHUA) generated $12.1M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.